Review
Accepted on 23 Dec 2024
Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs)
in Pharmacology of Anti-Cancer Drugs
Review
Accepted on 23 Dec 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 23 Dec 2024
in Nutritional Epidemiology
Original Research
Accepted on 23 Dec 2024
in Psychology of Language
Original Research
Accepted on 23 Dec 2024
in Neuropsychology
Original Research
Accepted on 23 Dec 2024
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Accepted on 23 Dec 2024
in Plant Bioinformatics
Original Research
Accepted on 23 Dec 2024
in Solid Earth Geophysics
Original Research
Accepted on 23 Dec 2024
in Plant Bioinformatics
Original Research
Accepted on 23 Dec 2024
in Alzheimer's Disease and Related Dementias
Original Research
Accepted on 23 Dec 2024
in Aging and Public Health
Original Research
Accepted on 23 Dec 2024
in Zoological Medicine
Mini Review
Accepted on 23 Dec 2024
in Sport Psychology
Original Research
Accepted on 23 Dec 2024
in Cancer Epidemiology and Prevention
Original Research
Accepted on 23 Dec 2024
in Cellular Neuropathology
Editorial
Accepted on 23 Dec 2024
in Regulatory Toxicology
Original Research
Accepted on 23 Dec 2024
in Atmospheric Science